SLC16A1 and neoplasm: Note that the impact may be indirect since MCT1 inhibition in oxidative tumor cells may favor the death of hypoxic glycolytic cells [26], and alteration in the fibroblast capacity to take up lactate and export pyruvate (both through MCT1) in tumors may reduce tumor cell proliferation [42].